Leishmania infantum promastigotes reduce entry of HIV-1 into macrophages through a lipophosphoglycan-mediated disruption of lipid rafts

Journal of Infectious Diseases

Volumn 197, Issue 12, 2008, Pages 1701-1708

  Garg, Ravendra ^a   Lodge, Robert ^a   Descoteaux, Albert ^b   Tremblay, Michel J ^a  

^a LAVAL UNIVERSITY   (Canada)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; GLYCOLIPID; LIPOPHOSPHOGLYCAN; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEISHMANIA INFANTUM; LIPID RAFT; MACROPHAGE; MICROENVIRONMENT; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROMASTIGOTE; TIME; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS REPLICATION; VISCERAL LEISHMANIASIS;

ANIMALS; CELLS, CULTURED; GLYCOSPHINGOLIPIDS; HIV-1; HUMANS; LEISHMANIA INFANTUM; MACROPHAGES; MEMBRANE MICRODOMAINS; TIME FACTORS; VIRUS REPLICATION;

EID: 46349096894     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/588146     Document Type: Article

References (40)

1. Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishmaniasis. Clin Microbiol Rev 2006; 19:111-26.
2. Anker M, Schaaf D. WHO report on global surveillance of epidemic-prone infectious diseases. Geneva: World Health Organization Department of Communicable Disease Surveillance and Response, 2000:121-7.
3. Cruz I, Nieto J, Moreno J, Canavate C, Desjeux P, Alvar J. Leishmania/HIV co-infections in the second decade. Indian J Med Res 2006; 123:357-88.
4. Molina R, Gradoni L, Alvar J. HIV and the transmission of Leishmania. Ann Trop Med Parasitol 2003; 97(Suppl 1):29-45.
5. Zhao C, Thibault S, Messier N, Ouellette M, Papadopoulou B, Tremblay MJ. In primary human monocyte-derived macrophages exposed to human immunodeficiency virus type 1, does the increased intracellular growth of Leishmania infantum rely on its enhanced uptake? J Gen Virol 2006; 87:1295-302.
6. Zhao C, Papadopoulou B, Tremblay MJ. Leishmania infantum enhances human immunodeficiency virus type-1 replication in primary human macrophages through a complex cytokine network. Clin Immunol 2004; 113:81-8.
7. Turco SJ, Descoteaux A. The lipophosphoglycan of Leishmania parasites. Annu Rev Microbiol 1992; 46:65-94.
8. Descoteaux A, Turco SJ. Glycoconjugates in Leishmania infectivity. Biochim Biophys Acta 1999; 1455:341-52.
9. Bernier R, Barbeau B, Tremblay MJ, Olivier M. The lipophosphoglycan of Leishmania donovani up-regulates HIV-1 transcription in T cells through the nuclear factor-kappaB elements. J Immunol 1998; 160:2881-8.
10. Easterbrook MD, Levy MH, Gomez AM, Turco SJ, Epand RM, Rosenthal KL. Inhibition of HIV-1-induced syncytia formation and infectivity by lipophosphoglycan from Leishmania. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10:496-505.
11. Genois N, Barbeau B, Olivier M, Tremblay MJ. Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle. Clin Exp Immunol 2001; 124:32-42.
12. Dornadula G, Zhang H, Shetty S, Pomerantz RJ. HIV-1 virions produced from replicating peripheral blood lymphocytes are more infectious than those from nonproliferating macrophages due to higher levels of intravirion reverse transcripts: implications for pathogenesis and transmission. Virology 1999; 253:10-16.
13. +-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J Virol 2002; 76:1004-14.
14. + T cells. J Virol 2002; 76:4709-22.
15. Privé C, Descoteaux A. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages. Eur J Immunol 2000; 30:2235-44.
16. El Fakhry Y, Ouellette M, Papadopoulou B. A proteomic approach to identify developmentally regulated proteins in Leishmania infantum. Proteomics 2002; 2:1007-17.
17. Aiken C. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J Virol 1997; 71:5871-7.
18. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27:305-18.
19. Alvar J, Canavate C, Gutierrez-Solar B, et al. Leishmania and human immunodeficiency virus co-infection: the first ten years. Clin Microbiol Rev 1997; 10:298-319.
20. Desjeux P, Alvar J. Leishmania/HIV co-infections: epidemiology in Europe. Ann Trop Med Parasitol 2003; 97(Suppl 1):3-15.
21. Ali A. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences. Ethiop Med J 2002; 40(Suppl 1):37-49.
22. Olivier M, Badaro R, Medrano FJ, Moreno J. The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms. Ann Trop Med Parasitol 2003; 97(Suppl 1): 79-98.
23. Pugliese A, Vidotto V, Beltramo T, Torre D. Phagocytic activity in human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 2005; 12:889-95.
24. Crowe S, Zhu T, Muller WA. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J Leukoc Biol 2003; 74:635-41.
25. Deretic V, Vergne I, Chua J, et al. Endosomal membrane traffic: convergence point targeted by Mycobacterium tuberculosis and HIV. Cell Microbiol 2004; 6:999-1009.
26. Kedzierska K, Crowe SM. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem 2002; 9:1893-903.
27. Bernier R, Turco SJ, Olivier M, Tremblay M. Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani. J Virol 1995; 69:7282-5.
28. Zhao C, Papadopoulou B, Tremblay MJ. Leishmania infantum promotes replication of HIV type 1 in human lymphoid tissue cultured ex vivo by inducing secretion of the proinflammatory cytokines TNF-alpha and IL-1 alpha. J Immunol 2004; 172:3086-93.
29. Desjardins M, Descoteaux A. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J Exp Med 1997; 185:2061-8.
30. Lodge R, Descoteaux A. Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania. Clin Immunol 2005; 114:256-65.
31. Chakraborty D, Banerjee S, Sen A, Banerjee KK, Das P, Roy S. Leishmania donovani affects antigen presentation of macrophage by disrupting lipid rafts. J Immunol 2005; 175:3214-24.
32. Dermine JF, Duclos S, Garin J, et al. Flotillin-1-enriched lipid raft domains accumulate on maturing phagosomes. J Biol Chem 2001; 276:18507-12.
33. Dermine JF, Goyette G, Houde M, Turco SJ, Desjardins M. Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages. Cell Microbiol 2005; 7:1263-70.
34. Miao L, Stafford A, Nir S, Turco SJ, Flanagan TD, Epand RM. Potent inhibition of viral fusion by the lipophosphoglycan of Leishmania donovani. Biochemistry 1995; 34:4676-83.
35. Tolson DL, Turco SJ, Pearson TW. Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani. Infect Immun 1990; 58:3500 -7.
36. Manes S, del Real G, Lacalle RA, et al. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep 2000; 1:190-6.
37. Harder T, Scheiffele P, Verkade P, Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol 1998; 141:929-42.
38. Rasmusson BJ, Flanagan TD, Turco SJ, Epand RM, Petersen NO. Fusion of Sendai virus and individual host cells and inhibition of fusion by lipophosphoglycan measured with image correlation spectroscopy. Biochim Biophys Acta 1998; 1404:338-52.
39. Takeda M, Leser GP, Russell CJ, Lamb RA. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci USA 2003; 100:14610-7.
40. Goletti D, Carrara S, Vincenti D, et al. Inhibition of HIV-1 replication in monocyte-derived macrophages by Mycobacterium tuberculosis. J Infect Dis 2004; 189:624-33.